Key statistics
On Thursday, Hemogenyx Pharmaceuticals PLC (HEMO:LSE) closed at 1.53, 52.50% above the 52 week low of 1.00 set on Nov 14, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 1.35 |
---|---|
High | 1.55 |
Low | 1.35 |
Bid | 1.50 |
Offer | 1.55 |
Previous close | 1.44 |
Average volume | 19.35m |
---|---|
Shares outstanding | 1.40bn |
Free float | 1.26bn |
P/E (TTM) | -- |
Market cap | 20.12m GBP |
EPS (TTM) | -0.0042 GBP |
Data delayed at least 20 minutes, as of Nov 21 2024 16:22 GMT.
More ▼
- Institutional Investment
- Schedule for Phase I Clinical Trial Opening
- Strategic Investment from Prevail Partners, LLC
- Half-year Report
- FLT3 Assay Ready for Phase I Trials at MD Anderson
- CDX Development Update
- Presentation at CBD S&T Conference
- Macrophage-Directed Therapies Summit Presentation
- Result of Annual General Meeting
- Operations Update
More ▼